<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/00E9A676-30AD-4AA0-A956-771A9169765C"><gtr:id>00E9A676-30AD-4AA0-A956-771A9169765C</gtr:id><gtr:name>Health Protection Agency Microbiological Services Porton</gtr:name><gtr:address><gtr:line1>Manor Farm Road
Porton Down</gtr:line1><gtr:city>Salisbury</gtr:city><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/00E9A676-30AD-4AA0-A956-771A9169765C" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>00E9A676-30AD-4AA0-A956-771A9169765C</gtr:id><gtr:name>Health Protection Agency Microbiological Services Porton</gtr:name><gtr:address><gtr:line1>Manor Farm Road
Porton Down</gtr:line1><gtr:city>Salisbury</gtr:city><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>234856.0</gtr:offerGrant><gtr:projectCost>469712.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>280938.0</gtr:offerGrant><gtr:projectCost>280938.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1529782F-9068-4364-888E-46E4FC4881F5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>1529782F-9068-4364-888E-46E4FC4881F5</gtr:id><gtr:name>Nottingham Trent University</gtr:name><gtr:address><gtr:line1>Burton Street</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG1 4BU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>180794.0</gtr:offerGrant><gtr:projectCost>180794.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0E898AF3-D0B6-4E94-B063-7ACEB35EDF9A" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>0E898AF3-D0B6-4E94-B063-7ACEB35EDF9A</gtr:id><gtr:name>Atlas Genetics Limited</gtr:name><gtr:address><gtr:line1>DERBY COURT EPSOM SQUARE , WHITE HORSE BUSINESS PARK</gtr:line1><gtr:city>TROWBRIDGE</gtr:city><gtr:postCode>BA14 0XG</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>160910.0</gtr:offerGrant><gtr:projectCost>268182.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/448539BD-1FB4-486D-9D7F-973FE0345F9D" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>448539BD-1FB4-486D-9D7F-973FE0345F9D</gtr:id><gtr:name>Randox Laboratories Limited</gtr:name><gtr:address><gtr:line1>55 Diamond Road</gtr:line1><gtr:city>Crumlin</gtr:city><gtr:postCode>BT29 4QY</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>133706.0</gtr:offerGrant><gtr:projectCost>267411.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4DDBBDEB-9C23-4DBB-9176-F8E51700B970"><gtr:id>4DDBBDEB-9C23-4DBB-9176-F8E51700B970</gtr:id><gtr:firstName>Sara</gtr:firstName><gtr:surname>Bolderstone</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=101191"><gtr:id>4F2F087B-D3AD-4856-A8B3-0BF9B8C4CA88</gtr:id><gtr:title>Molecular Prognostic Test for Sepsis for use in Point of Care Setting</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>101191</gtr:grantReference><gtr:abstractText>Diagnosis of SIRS &amp;amp; sepsis and identification of patients likely to progress to severe sepsis or septic shock is challenging due to a lack of definitive diagnostic tests. This project aims to identify biomarker panels for diagnosis and prognosis of SIRS, sepsis and likely progression to severe sepsis from patient host biomarkers identified in previously published studies. These will be comprehensively assessed in a combined study using temporally retrieved blood samples from a new cohort of SIRS &amp;amp; sepsis patients and identified using the sophisticated ANN analysis methods of NTU. Validated panels of markers will be used to build new diagnostic and prognostic ?point of care? and laboratory-based tests on the Atlas Genetics? and Randox Laboratories? platforms, which will be used to inform patient treatment and long-term care. This study is only possible through the expertise and unique collaboration between the commercial partners Atlas and Randox, the HPA, NTU, CCA and SARTRE.</gtr:abstractText><gtr:fund><gtr:end>2014-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2012-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>991204</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">101191</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>